Nonviral gene delivery to the rat kidney with polyethylenimine

被引:161
作者
Boletta, A
Benigni, A
Lutz, J
Remuzzi, G
Soria, MR
Monaco, L
机构
[1] SAN RAFFAELE SCI INST,DIBIT,I-20132 MILAN,ITALY
[2] MARIO NEGRI INST PHARMACOL RES,I-24100 BERGAMO,ITALY
关键词
D O I
10.1089/hum.1997.8.10-1243
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The aim of this study was to establish a nonviral method for gene delivery to the rat kidney. To this purpose, a panel of reagents was tested, including a monocationic lipid, DOTAP, a polycationic lipid, DOGS (or Transfectam), and three different forms of the cationic polymer polyethyleninine (PEI). A comparison among these compounds was performed in vivo, using luciferase as reporter gene. Complexes containing 10 mu g of DNA were injected into the left renal artery of rats and allowed to remain in contact with the kidney for 10 min. Forty-eight hours later, luciferase expression levels in kidney extracts were measured, Kidneys injected with DNA complexed to the branched, 25-kD PEI polymer (PEI 25k) yielded activity levels significantly higher than control, sham-operated kidneys (2.7 X 10(4) vs, 5.2 X 10(3) RLU/kidney, respectively), whereas the other transfecting agents did not yield significant activity over controls, PEI 25k was therefore chosen for further optimization of transfection conditions. Dose-dependent luciferase expression was shown for 10, 50, and 100 mu g of PEI-complexed DNA, reaching maximal levels of 2.4 X 10(5) RLU/kidney at 100 mu g DNA, The optimal PEI nitrogen/DNA phosphate molar ratio was 10 equivalents. Luciferase activity peaked at 2 days, was still significantly higher than controls at 7 days, and was undetectable at 14 days post-injection. Using beta-galactosidase (beta-Gal) as a reporter, transgene expression was localized almost exclusively in proximal tubular cells.
引用
收藏
页码:1243 / 1251
页数:9
相关论文
共 35 条
[11]  
GLAUMANN B, 1977, VIRCHOWS ARCH B, V24, P1
[12]   POLYAMIDOAMINE CASCADE POLYMERS MEDIATE EFFICIENT TRANSFECTION OF CELLS IN CULTURE [J].
HAENSLER, J ;
SZOKA, FC .
BIOCONJUGATE CHEMISTRY, 1993, 4 (05) :372-379
[13]  
Heikkila P, 1996, GENE THER, V3, P21
[14]   GLOMERULOSCLEROSIS INDUCED BY IN-VIVO TRANSFECTION OF TRANSFORMING GROWTH-FACTOR-BETA OR PLATELET-DERIVED GROWTH-FACTOR GENE INTO THE RAT-KIDNEY [J].
ISAKA, Y ;
FUJIWARA, Y ;
UEDA, N ;
KANEDA, Y ;
KAMADA, T ;
IMAI, E .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2597-2601
[15]   GENE-TRANSFER INTO THE RAT RENAL GLOMERULUS VIA A MESANGIAL CELL VECTOR - SITE-SPECIFIC DELIVERY, IN-SITU AMPLIFICATION, AND SUSTAINED EXPRESSION OF AN EXOGENOUS GENE IN-VIVO [J].
KITAMURA, M ;
TAYLOR, S ;
UNWIN, R ;
BURTON, S ;
SHIMIZU, F ;
FINE, LG .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02) :497-505
[16]   INTEGRATION OF EMBRYONIC NEPHROGENIC CELLS CARRYING A REPORTER GENE INTO FUNCTIONING NEPHRONS [J].
KOSEKI, C ;
HERZLINGER, D ;
ALAWQATI, Q .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (03) :C550-C554
[17]   CANCER GENE-THERAPY USING PLASMID DNA - PHARMACOKINETIC STUDY OF DNA FOLLOWING INJECTION IN MICE [J].
LEW, D ;
PARKER, SE ;
LATIMER, T ;
ABAI, AM ;
KUWAHARARUNDELL, A ;
DOH, SG ;
YANG, ZY ;
LAFACE, D ;
GROMKOWSKI, SH ;
NABEL, GJ ;
MANTHORPE, M ;
NORMAN, J .
HUMAN GENE THERAPY, 1995, 6 (05) :553-564
[18]  
MEYER KB, 1995, GENE THER, V2, P450
[19]   Expression of recombinant human granulocyte colony-stimulating factor in CHO dhfr(-) cells: New insights into the in vitro amplification expression system [J].
Monaco, L ;
Tagliabue, R ;
Giovanazzi, S ;
Bragonzi, A ;
Soria, MR .
GENE, 1996, 180 (1-2) :145-150
[20]  
MONACO L, 1994, BIOTECHNOL APPL BIOC, V20, P157